A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...

Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...

BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...

Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency ...

Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...

Robert F. Kennedy’s right-hand man was briefly Laura Loomer’s latest scalp, but had his job saved thanks to the intervention ...

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.

WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene ...

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than three months ago.

Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA. He has our enthusiastic support. Prasad is ...

No matter what regulatory decisions Dr. Vinay Prasad makes moving forward, the fact that he was willing to legitimize and ...